Longitudinal evaluation of neuroinflammation and oxidative stress in a mouse model of Alzheimer disease using positron emission tomography

Longitudinal evaluation of neuroinflammation and oxidative stress in a mouse model of Alzheimer disease using positron emission tomography

Abstract Background Validation of new biomarkers of Alzheimer disease (AD) is crucial for the successful development and implementation of treatment strategies. Additional to traditional AT(N) biomarkers, neuroinflammation biomarkers, such as translocator protein (TSPO) and cystine/glutamine antipor...

Full description

Bibliographic Details
Main Authors:	Luka Rejc, Vanessa Gómez-Vallejo, Ana Joya, Gemma Arsequell, Ander Egimendia, Pilar Castellnou, Xabier Ríos-Anglada, Unai Cossío, Zuriñe Baz, Leyre Iglesias, Estibaliz Capetillo-Zarate, Pedro Ramos-Cabrer, Abraham Martin, Jordi Llop
Format:	Article
Language:	English
Published:	BMC 2022-06-01
Series:	Alzheimer’s Research & Therapy
Subjects:	TSPO Oxidative stress Positron emission tomography Alzheimer disease
Online Access:	https://doi.org/10.1186/s13195-022-01016-5

Similar Items

Translocator protein (TSPO) is a biomarker of Zika virus (ZIKV) infection-associated neuroinflammation
by: Carla Bianca Luena Victorio, et al.
Published: (2024-12-01)

In Vivo TSPO Signal and Neuroinflammation in Alzheimer’s Disease
by: Benjamin B. Tournier, et al.
Published: (2020-08-01)

Longitudinal positron emission tomography and postmortem analysis reveals widespread neuroinflammation in SARS-CoV-2 infected rhesus macaques
by: Juliana M. Nieuwland, et al.
Published: (2023-07-01)

Control of Neuroinflammation through Radiation-Induced Microglial Changes
by: Alexandra Boyd, et al.
Published: (2021-09-01)

Neuroinflammation trajectories precede cognitive impairment after experimental meningitis—evidence from an in vivo PET study
by: Vijayasree V. Giridharan, et al.
Published: (2020-01-01)

[ 18F]FEPPA PET imaging for monitoring CD68-positive microglia/macrophage neuroinflammation in nonhuman primates
by: Matthew Zammit, et al.
Published: (2020-08-01)

Neuroinflammation as potential precursor of leukoencephalopathy in early-stage breast cancer patients: A cross-sectional PET-MRI study
by: Gwen Schroyen, et al.
Published: (2022-04-01)

18 kDa translocator protein positron emission tomography facilitates early and robust tumor detection in the immunocompetent SB28 glioblastoma mouse model
by: Laura M. Bartos, et al.
Published: (2022-10-01)

A pilot [11C]PBR28 PET/MRI study of neuroinflammation and neurodegeneration in chronic stroke patients
by: Judith D. Schaechter, et al.
Published: (2021-11-01)

APOE ε4 gene dose effect on imaging and blood biomarkers of neuroinflammation and beta-amyloid in cognitively unimpaired elderly
by: Anniina Snellman, et al.
Published: (2023-04-01)

Assessment of Translocator Protein Density, as Marker of Neuroinflammation, in Major Depressive Disorder: A Pilot, Multicenter, Comparative, Controlled, Brain PET Study (INFLADEP Study)
by: Antoine Yrondi, et al.
Published: (2018-07-01)

18F-VC701-PET and MRI in the in vivo neuroinflammation assessment of a mouse model of multiple sclerosis
by: Sara Belloli, et al.
Published: (2018-02-01)

The TSPO Ligands MGV-1 and 2-Cl-MGV-1 Differentially Inhibit the Cigarette Smoke-Induced Cytotoxicity to H1299 Lung Cancer Cells
by: Nidal Zeineh, et al.
Published: (2021-05-01)

Increased transcription of TSPO, HDAC2, and HDAC6 in the amygdala of males with alcohol use disorder
by: Luana Martins De Carvalho, et al.
Published: (2021-02-01)

Translocator protein TSPO 18 kDa and its ligands: a promising approach to the creation of new neuropsychotropic drug
by: G. V. Mokrov, et al.
Published: (2018-11-01)

TSPO knockdown attenuates OGD/R-induced neuroinflammation and neural apoptosis by decreasing NLRP3 inflammasome activity through PPARγ pathway
by: Kai Wang, et al.
Published: (2022-09-01)

In vivo assessment of neuroinflammation in progressive multiple sclerosis: a proof of concept study with [18F]DPA714 PET
by: Marloes H. J. Hagens, et al.
Published: (2018-11-01)

Neurogenic Potential of the 18-kDa Mitochondrial Translocator Protein (TSPO) in Pluripotent P19 Stem Cells
by: Laura González-Blanco, et al.
Published: (2021-10-01)

Impact of Cholesterol on the Stability of Monomeric and Dimeric Forms of the Translocator Protein TSPO: A Molecular Simulation Study
by: Zeineb Si Chaib, et al.
Published: (2020-09-01)

A translocator protein 18 kDa agonist protects against cerebral ischemia/reperfusion injury
by: Han-Dong Li, et al.
Published: (2017-07-01)

Glial activation is moderated by sex in response to amyloidosis but not to tau pathology in mouse models of neurodegenerative diseases
by: Gloria Biechele, et al.
Published: (2020-12-01)

TSPO PET detects acute neuroinflammation but not diffuse chronically activated MHCII microglia in the rat
by: Nassir U. Al-Khishman, et al.
Published: (2020-09-01)

Search of the correlation berween anxiolytic effect of original derivative of pyrrolo [1,2-A] pyrazine TSPO-LIGAND (GML-1) and its concentrations in the rat blood plasma
by: M. A. Yarkova, et al.
Published: (2018-03-01)

Feasibility of TSPO-Specific Positron Emission Tomography Radiotracer for Evaluating Paracetamol-Induced Liver Injury
by: Daehee Kim, et al.
Published: (2021-09-01)

Quantification of Huntington’s Disease Related Markers in the R6/2 Mouse Model
by: Estibaliz Etxeberria-Rekalde, et al.
Published: (2021-01-01)

Synthesis and evaluation of TSPO-targeting radioligand [18F]F-TFQC for PET neuroimaging in epileptic rats
by: Wenhui Fu, et al.
Published: (2025-02-01)

Translocator protein PET imaging in temporal lobe epilepsy: A reliable test-retest study using asymmetry index
by: Mohammad Mahmud, et al.
Published: (2023-04-01)

Associations between sex, body mass index and the individual microglial response in Alzheimer’s disease
by: Gloria Biechele, et al.
Published: (2024-01-01)

TSPO Deficiency Exacerbates GSDMD-Mediated Macrophage Pyroptosis in Inflammatory Bowel Disease
by: Xue Zhang, et al.
Published: (2022-03-01)

Shotgun Proteomics of Co-Cultured Leukemic and Bone Marrow Stromal Cells from Different Species as a Preliminary Approach to Detect Intercellular Protein Transfer
by: Abraham Josué Nevárez-Ramírez, et al.
Published: (2023-04-01)

Expression of Translocator Protein and [18F]-GE180 Ligand Uptake in Multiple Sclerosis Animal Models
by: Anne Nack, et al.
Published: (2019-01-01)

Clinical heterogeneity of neuro-inflammatory PET profiles in early Alzheimer’s disease
by: Dominique Gouilly, et al.
Published: (2023-07-01)

A Systematic Review on Dementia and Translocator Protein (TSPO): When Nuclear Medicine Highlights an Underlying Expression
by: Miriam Conte, et al.
Published: (2023-03-01)

The 18 kDa translocator protein is associated with microglia in the hippocampus of non-demented elderly subjects
by: Benjamin B. Tournier, et al.
Published: (2022-01-01)

Translocator Protein Ligand Etifoxine Attenuates MPTP-Induced Neurotoxicity
by: Qi Tian, et al.
Published: (2022-05-01)

Quantifying disease activity in rheumatoid arthritis with the TSPO PET ligand 18F-GE-180 and comparison with 18F-FDG and DCE-MRI
by: Marius de Groot, et al.
Published: (2019-12-01)

Paeoniflorin elicits the anti-proliferative effects on glioma cell via targeting translocator protein 18 KDa
by: Zhuo-wei Gao, et al.
Published: (2021-01-01)

In vitro and pilot in vivo imaging of 18 kDa translocator protein (TSPO) in inflammatory vascular disease
by: Romain Schollhammer, et al.
Published: (2021-05-01)

Translocator Protein 18 kDa (TSPO) Deficiency Inhibits Microglial Activation and Impairs Mitochondrial Function
by: Rumeng Yao, et al.
Published: (2020-06-01)

Microglia activation in a pediatric rabbit model of tuberculous meningitis
by: Elizabeth W. Tucker, et al.
Published: (2016-12-01)